Symbols / UG Stock $7.01 +1.45% United-Guardian, Inc.

Consumer Defensive • Household & Personal Products • United States • NGM
UG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Household & Personal Products
CEO —
Exch · Country NGM · United States
Market Cap 32.21M
Enterprise Value 24.17M
Income 2.36M
Sales 10.94M
FCF (ttm) 802.76K
Book/sh 2.44
Cash/sh 1.75
Employees 23
Insider 10d —
IPO Mar 17, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 96.15%
P/E 13.48
Forward P/E —
PEG 1.12
P/S 2.94
P/B 2.87
P/C —
EV/EBITDA 10.12
EV/Sales 2.21
Quick Ratio 6.85
Current Ratio 8.05
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 0.52
EPS next Y —
EPS Growth 46.00%
Revenue Growth 15.80%
EPS Gr Q/Q 46.00%
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA 11.17%
ROE 21.75%
ROIC —
Gross Margin 47.62%
Oper. Margin 22.37%
Profit Margin 21.61%
Shs Outstand 4.59M
Shs Float 2.90M
Insider Own 35.85%
Instit Own 20.79%
Short Float 0.30%
Short Ratio 1.74
Short Interest 9.67K
52W High 9.88
vs 52W High -29.05%
52W Low 5.58
vs 52W Low 25.63%
Beta 0.97
Impl. Vol. —
Rel Volume 0.54
Avg Volume 4.96K
Volume 2.69K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $6.91
Price $7.01
Change 1.45%
About

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$7.01
Latest analyst target
3. DCF / Fair value
$3.15
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.01
Low
—
High
—
Mean
—
News
RSS: Latest UG news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-21 GLOBUS KENNETH H Director — 7,480 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
10.55
-13.43%
12.18
+11.91%
10.89
-14.28%
12.70
Operating Revenue
10.55
-13.43%
12.18
+11.91%
10.89
-14.28%
12.70
Cost Of Revenue
5.40
-5.54%
5.72
+4.42%
5.48
-8.62%
6.00
Reconciled Cost Of Revenue
5.40
-5.54%
5.72
+4.42%
5.48
-8.62%
6.00
Gross Profit
5.14
-20.42%
6.46
+19.51%
5.41
-19.35%
6.70
Operating Expense
2.90
+2.99%
2.81
+10.66%
2.54
-4.59%
2.66
Research And Development
0.46
+1.50%
0.46
-1.55%
0.46
-5.46%
0.49
Other Operating Expenses
2.43
+3.28%
2.36
+13.39%
2.08
-4.40%
2.17
Total Expenses
8.30
-2.73%
8.54
+6.40%
8.02
-7.38%
8.66
Operating Income
2.24
-38.48%
3.65
+27.38%
2.86
-29.08%
4.04
Total Operating Income As Reported
2.24
-38.48%
3.65
+27.38%
2.86
-29.08%
4.04
EBITDA
2.35
-37.17%
3.74
+26.07%
2.97
-28.85%
4.17
Normalized EBITDA
1.95
-40.51%
3.28
+27.12%
2.58
-48.20%
4.98
Reconciled Depreciation
0.11
+12.84%
0.10
-9.27%
0.11
-21.95%
0.14
EBIT
2.24
-38.48%
3.65
+27.38%
2.86
-29.08%
4.04
Total Unusual Items
0.40
-13.43%
0.46
+19.06%
0.39
+147.90%
-0.81
Total Unusual Items Excluding Goodwill
0.40
-13.43%
0.46
+19.06%
0.39
+147.90%
-0.81
Net Income
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Pretax Income
2.64
-35.67%
4.11
+26.38%
3.25
+0.72%
3.23
Other Income Expense
0.40
-13.43%
0.46
+19.06%
0.39
+147.90%
-0.81
Gain On Sale Of Security
0.40
-13.43%
0.46
+19.06%
0.39
+147.90%
-0.81
Tax Provision
0.54
-37.35%
0.86
+28.11%
0.67
+1.71%
0.66
Tax Rate For Calcs
0.00
-2.75%
0.00
+1.33%
0.00
+0.98%
0.00
Tax Effect Of Unusual Items
0.08
-15.81%
0.10
+20.65%
0.08
+148.37%
-0.17
Net Income Including Noncontrolling Interests
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Net Income From Continuing Operation Net Minority Interest
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Net Income From Continuing And Discontinued Operation
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Net Income Continuous Operations
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Normalized Income
1.79
-38.06%
2.89
+26.92%
2.27
-29.26%
3.21
Net Income Common Stockholders
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Diluted EPS
0.46
-35.21%
0.71
+26.79%
0.56
+0.00%
0.56
Basic EPS
0.46
-35.21%
0.71
+26.79%
0.56
+0.00%
0.56
Basic Average Shares
4.59
+0.00%
4.59
+0.00%
4.59
+0.00%
4.59
Diluted Average Shares
4.59
+0.00%
4.59
+0.00%
4.59
+0.00%
4.59
Diluted NI Availto Com Stockholders
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
13.11
-4.99%
13.80
+6.77%
12.92
+21.45%
10.64
Current Assets
12.20
-3.66%
12.67
+3.37%
12.25
+22.89%
9.97
Cash Cash Equivalents And Short Term Investments
8.57
-8.77%
9.40
+3.34%
9.09
+40.26%
6.48
Cash And Cash Equivalents
1.25
-33.30%
1.88
-77.25%
8.24
+892.61%
0.83
Cash Equivalents
1.00
-31.87%
1.47
-81.39%
7.90
+1432.30%
0.52
Cash Financial
0.25
-38.49%
0.40
+19.05%
0.34
+8.06%
0.31
Other Short Term Investments
7.32
-2.66%
7.52
+783.64%
0.85
-84.94%
5.65
Receivables
1.59
+11.09%
1.43
-8.83%
1.57
+9.76%
1.43
Accounts Receivable
1.59
+11.09%
1.43
-8.83%
1.57
+9.76%
1.43
Gross Accounts Receivable
1.60
+11.18%
1.44
-8.89%
1.58
+9.39%
1.45
Allowance For Doubtful Accounts Receivable
-0.02
-19.71%
-0.01
+13.98%
-0.02
+16.90%
-0.02
Inventory
1.51
+3.84%
1.45
+18.67%
1.22
-26.82%
1.67
Raw Materials
0.44
-1.14%
0.45
-5.96%
0.48
-20.73%
0.60
Work In Process
0.01
-90.62%
0.06
-36.26%
0.09
+457.44%
0.02
Finished Goods
1.06
+12.07%
0.95
+44.32%
0.65
-37.89%
1.05
Prepaid Assets
0.33
+81.64%
0.18
+1.59%
0.18
-4.86%
0.19
Other Current Assets
0.21
+0.02%
0.21
+8.40%
0.19
-5.02%
0.20
Total Non Current Assets
0.91
-19.84%
1.13
+68.89%
0.67
+0.06%
0.67
Net PPE
0.91
-5.14%
0.96
+54.46%
0.62
+10.74%
0.56
Gross PPE
8.21
+0.72%
8.15
+5.61%
7.72
+2.19%
7.55
Accumulated Depreciation
-7.30
-1.50%
-7.19
-1.35%
-7.10
-1.51%
-6.99
Properties
0.00
0.00
0.00
0.00
Land And Improvements
0.07
+0.00%
0.07
+0.00%
0.07
+0.00%
0.07
Buildings And Improvements
3.35
+0.48%
3.34
+12.09%
2.98
+2.79%
2.90
Machinery Furniture Equipment
4.79
+0.91%
4.74
+1.57%
4.67
+1.85%
4.59
Non Current Deferred Assets
0.00
-100.00%
0.18
+244.39%
0.05
-53.93%
0.11
Non Current Deferred Taxes Assets
0.00
-100.00%
0.18
+244.39%
0.05
-53.93%
0.11
Total Liabilities Net Minority Interest
1.88
-1.98%
1.91
+24.78%
1.53
+11.69%
1.37
Current Liabilities
1.67
-12.81%
1.91
+24.78%
1.53
+11.69%
1.37
Payables And Accrued Expenses
1.28
+3.82%
1.23
+26.45%
0.97
+32.69%
0.73
Payables
0.49
+10.23%
0.45
+186.77%
0.16
+201.57%
0.05
Accounts Payable
0.48
+13.13%
0.43
+216.11%
0.13
+342.05%
0.03
Dividends Payable
0.01
-47.03%
0.02
+1.26%
0.02
+0.21%
0.02
Current Accrued Expenses
0.79
+0.18%
0.79
-4.03%
0.82
+19.93%
0.68
Pensionand Other Post Retirement Benefit Plans Current
0.18
-54.97%
0.41
+36.82%
0.30
+9.70%
0.27
Total Tax Payable
—
—
—
0.00
Income Tax Payable
—
—
—
0.00
Current Deferred Liabilities
0.01
0.00
-100.00%
0.02
0.00
Current Deferred Revenue
0.01
0.00
-100.00%
0.02
0.00
Total Non Current Liabilities Net Minority Interest
0.21
0.00
0.00
0.00
Non Current Deferred Liabilities
0.21
0.00
—
0.00
Non Current Deferred Taxes Liabilities
0.21
0.00
—
0.00
Stockholders Equity
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Common Stock Equity
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Capital Stock
0.46
+0.00%
0.46
+0.00%
0.46
+0.00%
0.46
Common Stock
0.46
+0.00%
0.46
+0.00%
0.46
+0.00%
0.46
Share Issued
4.59
+0.00%
4.59
+0.00%
4.59
+0.00%
4.59
Ordinary Shares Number
4.59
+0.00%
4.59
+0.00%
4.59
+0.00%
4.59
Retained Earnings
10.77
-5.70%
11.42
+4.52%
10.93
+24.09%
8.81
Total Equity Gross Minority Interest
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Total Capitalization
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Working Capital
10.53
-2.04%
10.75
+0.30%
10.72
+24.68%
8.60
Invested Capital
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Net Tangible Assets
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Tangible Book Value
11.23
-5.48%
11.88
+4.34%
11.39
+22.90%
9.27
Current Provisions
0.19
-29.55%
0.28
+11.65%
0.25
-32.86%
0.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1.97
-43.26%
3.47
+10.23%
3.14
+24.53%
2.53
Cash Flow From Continuing Operating Activities
1.97
-43.26%
3.47
+10.23%
3.14
+24.53%
2.53
Net Income From Continuing Operations
2.11
-35.23%
3.25
+25.94%
2.58
+0.46%
2.57
Depreciation Amortization Depletion
0.11
+12.84%
0.10
-9.27%
0.11
-21.95%
0.14
Depreciation And Amortization
0.11
+12.84%
0.10
-9.27%
0.11
-21.95%
0.14
Provisionand Write Offof Assets
0.00
+112.30%
-0.02
+18.90%
-0.02
-170.78%
0.03
Deferred Tax
0.38
+407.43%
-0.12
-308.79%
0.06
+130.77%
-0.19
Deferred Income Tax
0.38
+407.43%
-0.12
-308.79%
0.06
+130.77%
-0.19
Operating Gains Losses
-0.03
-27.31%
-0.03
+70.37%
-0.09
-108.69%
1.05
Gain Loss On Investment Securities
-0.03
-27.31%
-0.03
+66.72%
-0.08
-107.75%
1.05
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
-0.60
-307.82%
0.29
-43.55%
0.51
+147.89%
-1.06
Change In Receivables
-0.16
-214.60%
0.14
+203.56%
-0.14
-135.20%
0.39
Changes In Account Receivables
-0.16
-214.60%
0.14
+203.56%
-0.14
-135.20%
0.39
Change In Inventory
-0.05
+74.34%
-0.21
-146.03%
0.47
+260.40%
-0.29
Change In Prepaid Assets
-0.15
-673.73%
-0.02
-198.68%
0.02
+109.84%
-0.19
Change In Payables And Accrued Expense
-0.25
-162.51%
0.40
+172.68%
0.15
+118.72%
-0.77
Change In Accrued Expense
-0.30
-388.86%
0.10
+155.90%
0.04
+113.42%
-0.31
Change In Payable
0.06
-80.80%
0.29
+179.29%
0.10
+122.17%
-0.47
Change In Account Payable
0.06
-80.80%
0.29
+179.29%
0.10
+127.34%
-0.38
Change In Other Working Capital
0.01
+178.57%
-0.02
-200.00%
0.02
+108.15%
-0.19
Investing Cash Flow
0.18
+102.48%
-7.08
-249.70%
4.73
+426.71%
0.90
Cash Flow From Continuing Investing Activities
0.18
+102.48%
-7.08
-249.70%
4.73
+426.71%
0.90
Net PPE Purchase And Sale
-0.06
+86.38%
-0.43
-161.34%
-0.17
-120.43%
-0.08
Purchase Of PPE
-0.06
+86.38%
-0.43
-161.34%
-0.17
-120.43%
-0.08
Capital Expenditure
-0.06
+86.38%
-0.43
-161.34%
-0.17
-120.43%
-0.08
Net Investment Purchase And Sale
0.23
+103.53%
-6.64
-236.06%
4.88
+421.89%
0.94
Purchase Of Investment
-12.94
-52.99%
-8.46
-1260.34%
-0.62
+67.81%
-1.93
Sale Of Investment
13.18
+625.96%
1.81
-67.03%
5.51
+91.97%
2.87
Net Other Investing Changes
—
—
0.01
-73.00%
0.04
Financing Cash Flow
-2.77
-0.38%
-2.76
-500.00%
-0.46
+85.29%
-3.12
Cash Flow From Continuing Financing Activities
-2.77
-0.38%
-2.76
-500.00%
-0.46
+85.29%
-3.12
Common Stock Dividend Paid
-2.77
-0.38%
-2.76
-500.00%
-0.46
+85.29%
-3.12
Cash Dividends Paid
-2.77
-0.38%
-2.76
-500.00%
-0.46
+85.29%
-3.12
Changes In Cash
-0.62
+90.19%
-6.37
-185.90%
7.41
+2377.17%
0.30
Beginning Cash Position
1.88
-77.25%
8.24
+892.61%
0.83
+56.33%
0.53
End Cash Position
1.25
-33.30%
1.88
-77.25%
8.24
+892.61%
0.83
Free Cash Flow
1.91
-37.10%
3.03
+1.83%
2.98
+21.58%
2.45
Income Tax Paid Supplemental Data
0.30
-71.38%
1.05
+75.13%
0.60
-46.67%
1.12
Change In Dividend Payable
—
—
—
—
Change In Income Tax Payable
—
—
0.00
+100.00%
-0.09
Change In Tax Payable
—
—
0.00
+100.00%
-0.09
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category